ARCHIVES

NCI, FDA Make Progress On Some Issues, Bu Differences Remain On Endpoints

This article is from The Cancer Letter archive.

Vol. 15 No. 43 | November 10, 1989

Download PDF Visit The Full Archive

Related Articles

Chemo Can Harm Liver, Affect Surgical Outcomes

May 26, 2006

Outside Experts Might Lengthen NDA Approval, Peck Asserts

September 7, 1990

Edwards’ NIH Pep Talk Sounded Like An Attack On The Cancer Program, But He Says It Wasn’t

March 8, 1974

Oxaliplatin Regimen May Beat Standard For Advanced Colorectal Cancer, NCI Says

May 3, 2002

Preyer Supported For Chairmanship

January 26, 1979

Dendritic Cell Vaccine May Boost Median Survival

March 25, 2011